Canadian guidelines on HIV pre- and postexposureprophylaxis: 2025 update
Tuesday, March 17th | 12-1pm EST
Updated guidelines on Pre- and Postexposure Prophylaxis (PrEP and PEP) medications were published in the Canadian Medical Association Journal in December 2025. These guidelines offers Canadian health care providers, community members and policy-makers the latest insights on prescribing HIV prevention medications, in an effort to ensure the life-saving drugs are equitably prescribed and bring down rising infection rates. The guidelines come at a critical time as research shows that HIV cases are spiking in Canada. The federal government reported 2,434 people newly diagnosed with HIV in Canada in 2023, which is a 35% increase over previous years. Marginalized communities face disproportionately higher cases, calling for more guidance and equitable prevention tools.
Learning objectives:(1) Introduce the updated guidelines (2) Reviewing best practices in clinical guideline development/
Watch the recording here:
Passcode: LK2Y+5@z
ABOUT THE SPEAKER: Dr. Darrell Tan
Darrell H. S. Tan is an infectious diseases physician and Clinician-Scientist at St.
Michael’s Hospital, where he leads the Options Collaboratory in HIV/STI Treatment
and Prevention Science. He is also an Associate Professor in the Department of
Medicine and Institute of Health Policy, Management and Evaluation at the
University of Toronto, with a cross-appointment in the Institute of Medical
Science. His research focuses on clinical trials and implementation science in the
areas of HIV prevention, HIV treatment and sexually transmitted infections (STIs). Dr. Tan holds a Tier 2 Canada Research Chair in Biomedical HIV/STI Prevention, is Co-Lead of the Prevention and Testing Think Tank of the CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research (CTN+) and is a member of the Governing Council of the International AIDS Society.
ABOUT THE MODERATOR: Marc Steben, M.D., C.C.F.P., F.C.F.P., D.E.S.S.
Family physician; Founding President and Past-President of IUSTI-Canada; Member of the Board, International Society for STD Research; Chair of the 2025 ISSTDR and IUSTI-World Joint Congress and Member of the Board of the International Papillomavirus society.
As a family physician, Marc concentrates his clinical interest on sexual health, mainly chronic genital diseases. Research, development and publications in the field include therapeutic approaches to chronic genital pain, genital herpes and development of HIV HPV prevention strategies.
